Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir in a diverse cohort of HIV-infected patients
NCT00764946Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Merck & Co.. Started Oct 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00764946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764946.